While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.
A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...
Moderna wins EU tender to supply COVID-19 vaccines for up to four years, offering diverse formats like prefilled syringes to ...
Moderna (MRNA) stock gained in the premarket after the company received a tender to supply its COVID-19 vaccine in the EU, ...
Under the resulting agreement, 17 participating countries can access Moderna's mRNA COVID-19 vaccine for up to four years. "This agreement presents an opportunity for Moderna to support and ...
The Agreement provides participating countries with the opportunity to diversify their mRNA COVID-19 vaccine supply and gain ...